Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|November 2, 2020
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma PatientsEliana Bignotti, Laura Zanotti, Paola Todeschini, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 30, 2026
Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor TreatmentMarina Momi, Elisa Salviato, Antonella Ravaggi, et al.American Journal of Obstetrics and Gynecology|March 10, 2007
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genesEliana Bignotti, Renata A Tassi, Stefano Calza, et al.Journal of Cellular and Molecular Medicine|July 16, 2016
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissuesEliana Bignotti, Stefano Calza, Renata A Tassi, et al.Gynecologic Oncology|May 27, 2006
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapyEliana Bignotti, Renata A Tassi, Stefano Calza, et al.The Laryngoscope|August 8, 2017
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancerLaura Zanotti, Alberto Paderno, Cesare Piazza, et al.Scientific Reports|September 7, 2017
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma PatientsMarika Vezzoli, Antonella Ravaggi, Laura Zanotti, et al.Gynecologic Oncology|October 27, 2005
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalitiesAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral responseElisabetta Bandiera, Laura Zanotti, Eliana Bignotti, et al.Plos One|December 5, 2014
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissuesChiara Romani, Stefano Calza, Paola Todeschini, et al.Pageof 7